Johnson & Johnson Pfizer Remicade

Johnson & Johnson Pfizer Remicade

FILE - In this July 30, 2013, file photo, people walk along a corridor at the headquarters of Johnson & Johnson in New Brunswick, N.J. A cheaper version of J&J's top-selling drug, the rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled a key patent on the drug invalid. J&J said Wednesday, Aug. 17, 2016, it plans to appeal the ruling. (AP Photo/Mel Evans, File)

Use Information This content is intended for editorial use only.
For other uses, additional clearances may be required.

16230778829653
August 17, 2016 05:38:02 PM
August 17, 2016 09:39:36 PM
Mel Evans
AP
ASSOCIATED PRESS
JULY 30 2013 FILE PHOTO
4650 x 3330 2.29 MB
New Brunswick, NEW JERSEY, UNITED STATES
NY115
STF
MCE KXS**NY** DG**NY** AG**NY**

This content is intended for editorial use only. For other uses, additional clearances may be required.

X

Message Box

Cancel
Ok
No
Yes